Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityNo recent work listed

Annie A. Wu

Matched on ORCID iD 0000-0002-0730-298X; OpenAlex author ID A5073746550. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 4 papers

Papers 9

  1. Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer. Co-author DOI 10.1136/jitc-2019-000351↗
  2. Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-3978↗
  3. A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-1025↗
  4. An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocar… Co-author DOI 10.18632/oncotarget.27586↗
  5. Current Status of Immunotherapies for Treating Pancreatic Cancer. Co-author DOI 10.1007/s11912-019-0811-5↗
  6. Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer. Co-author DOI 10.1172/jci.insight.122857↗
  7. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-1383↗
  8. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Co-author DOI 10.1126/scisignal.aaa5823↗
  9. Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue. Co-author DOI 10.3791/4059↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elizabeth M. Jaffee · 8 shared papers, 2013–2020 · strength 0.62
  2. Lei Zheng · 5 shared papers, 2013–2020 · strength 0.31
  3. Dung Thi Le · 3 shared papers, 2020 · strength 0.26
  4. Daniel A. Laheru · 3 shared papers, 2020 · strength 0.26
  5. Robert A. Anders · 4 shared papers, 2013–2020 · strength 0.25
  6. Katherine M. Bever · 3 shared papers, 2013–2020 · strength 0.21
  7. Andrew H. Ko · 2 shared papers, 2020 · strength 0.17
  8. Elana Judith Fertig · 2 shared papers, 2020 · strength 0.17
  9. Valerie Lee · 1 shared paper, 2019 · strength 0.16
  10. Elaine O. Bigelow · 2 shared papers, 2013–2020 · strength 0.12
  11. Kelly Foley · 2 shared papers, 2015–2017 · strength 0.10
  12. Agnieszka A. Rucki · 2 shared papers, 2015–2017 · strength 0.10
  13. Qian Xiao · 2 shared papers, 2015–2017 · strength 0.10
  14. Noelle R. Jurcak · 1 shared paper, 2020 · strength 0.09
  15. Ding Ding · 1 shared paper, 2020 · strength 0.09
  16. Kenji Fujiwara · 1 shared paper, 2020 · strength 0.09
  17. Brian T. Herbst · 1 shared paper, 2020 · strength 0.09
  18. Stephen T. Muth · 1 shared paper, 2020 · strength 0.09
  19. May Tun Saung · 1 shared paper, 2020 · strength 0.09
  20. Keyu Li · 1 shared paper, 2020 · strength 0.09
  21. Alex B. Blair · 1 shared paper, 2020 · strength 0.09
  22. Nan Niu · 1 shared paper, 2020 · strength 0.09
  23. Won Jin Ho · 1 shared paper, 2020 · strength 0.09
  24. Andrea Wang‐Gillam · 1 shared paper, 2020 · strength 0.09
  25. Lisa M. Coussens · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.